PER
Click for more information
4.65% 9.0¢ percheron therapeutics limited

$36.8m raise, page-125

  1. RYNZN
    3,146 Posts.
    lightbulb Created with Sketch. 560
    clock Created with Sketch.
    31/10/21
    20:51
    Post #: 57215559
    So anyway....

    will Dr Voit be our PI?

    will the market react like crazy upon notification of a large oversubscription? (If this is true)

    Will we dose non ambulant?

    Will there be placebo?

    Will there be a higher dose than 25ml?

    Will the raise be for anything other than the (expected) Europe trial?

    Will they announce how long rnrollment might take / when first dose is administered...

    still a lot to discover.
    ANP Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 18  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS PLS: HotCopper's Most Discussed Stock of The Week!
right-arrow Created with Sketch.
NEWS TRENDING: High grade drilling assays
right-arrow Created with Sketch.
NEWS Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat
right-arrow Created with Sketch.
LU7 Discover the world of North American lithium chemicals with the "Dream Team"
right-arrow Created with Sketch.
NEWS Resource skyrockets 80% to 91Moz AgEq – exceptional grades and more drilling to come
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢ 		Change
0.004(4.65%) 		Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.